Please assess the completion status of the following clinical trial:

Trial Title: Mifepristone Versus Laminaria for Cervical Ripening in Midtrimester Induction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* pregnant women with fetal anomalies, aneuploidy, or demise at 15-22 weeks gestation~* age greater than 16~* able to speak English~Exclusion Criteria:~* prior uterine scar or~* allergy or history of bad reaction to any of the study drugs or~* history of chronic adrenal failure or~* porphyria or~* concurrent long-term corticosteroid treatment

- Gender: FEMALE
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).